MCL-1 upregulation by HTLV-1c proteins creates a viral Achilles' heel: exploiting this anti-apoptotic dependence enables precision eradication of infected reservoirs through dual antiretroviral/MCL-1 inhibitor therapy, selectively collapsing infected cell survival machinery while preserving healthy T-cell pools.